Stay updated on NSCLC Carboplatin+Pemetrexed+Bevacizumab+/-Atezolizumab Clinical Trial

Sign up to get notified when there's something new on the NSCLC Carboplatin+Pemetrexed+Bevacizumab+/-Atezolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the NSCLC Carboplatin+Pemetrexed+Bevacizumab+/-Atezolizumab Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Minor metadata updates (Last Update Posted date) with no changes to core content such as eligibility criteria, primary/secondary outcomes, or study design. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-10-27T21:04:05.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    Added a government-operating-status notice and a version bump to v3.2.0; removed the previous version label v3.1.0.
    Difference
    2%
    Check dated 2025-10-06T08:14:19.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Added updated contact details (phone and email) and a new Revision tag (v3.1.0) while removing the old Revision tag (v3.0.2).
    Difference
    0.1%
    Check dated 2025-09-29T04:45:59.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Version upgraded from v3.0.1 to v3.0.2, and the 'Back to Top' link was removed.
    Difference
    0.1%
    Check dated 2025-09-14T23:10:02.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-09-07T19:47:20.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    The web page has been updated to include a new facility name and location, along with a list of publications related to a clinical trial, while removing specific location details and drug information.
    Difference
    5%
    Check dated 2025-08-31T12:35:45.000Z thumbnail image

Stay in the know with updates to NSCLC Carboplatin+Pemetrexed+Bevacizumab+/-Atezolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the NSCLC Carboplatin+Pemetrexed+Bevacizumab+/-Atezolizumab Clinical Trial page.